author-photo

Sung-Bae Kim

University of Ulsan
Asan Medical Center

636

Papers

14453

Citations

Citation Trend

Filter By

Papers (636) Sort By

Journal Conference Others

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

2021 The Lancet
Show All
- Source
- Cite
- Save
Citations (10)
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial.

2021 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (33)
Root extract of Angelica reflexa B.Y.Lee reduces allergic lung inflammation by regulating Th2 cell activation.

2021 Journal of Ethnopharmacology
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of the Effectiveness and Clinical Outcome of Everolimus Followed by CDK4/6 Inhibitors with the Opposite Treatment Sequence in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer.

2021 Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (0)
Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (17)
Palbociclib combined with endocrine treatment in breast cancer patients with high relapse risk after neoadjuvant chemotherapy: Subgroup analyses of premenopausal patients in PENELOPE-B.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Alpha-smooth muscle actin expression in the stroma predicts resistance to trastuzumab in patients with early-stage HER2-positive breast cancer.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab.

2021 Journal of Breast Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer.

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (0)
Palbociclib Plus Fulvestrant in Korean Patients from PALOMA-3 With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

2021 Journal of Breast Cancer
Show All
- Source
- Cite
- Save
Citations (1)